Catriona Crombie talks to Rare Revolution about LifeArc’s investment of more than £100 million into rare disease research by 2030

Catriona discusses why LifeArc is well placed to help overcome some of the obstacles in rare disease research

Groundbreaking new £100m LifeArc programme aims to improve the lives of people living with a rare disease

Brings together the world-leading expertise of Health Data Research UK, University of Edinburgh, LifeArc, Eisai and Gates Ventures